Skip to main content
Clinical Trials/JPRN-UMIN000027009
JPRN-UMIN000027009
Recruiting
未知

Prospective, multicenter study for prediction of therapeutic effect of FOLFIRINOX with analyzing 5FU metabolism to aim the tailor-made therapy for unresectable pancreatic cancer. - Prospective, multicenter study for prediction of therapeutic effect of FOLFIRINOX with analyzing 5FU metabolism to aim the tailor-made therapy for unresectable pancreatic cancer.

Okayama university hospital0 sites50 target enrollmentApril 16, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Okayama university hospital
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 16, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Homotype of UGT1A1 genotype including \*28/\*28, \*6/\*6 and\*6/\*28 Evident pleural effusion, ascites, pericardial effusion or peritoneal metastasis on CT before enrollment Pulmonary fibrosis or interstitial pneumonia Watery stool within 3 days before enrollment Uncontrolled diabetes mellitus Any serious complication

Outcomes

Primary Outcomes

Not specified

Similar Trials